Im vergangenen Jahr erzielte Haemonetics Corp für sein leistungsstärkstes Segment, Plasma products and services, Einnahmen von 563.73M USD. Die Region United States leistete den größten Beitrag mit 1.01B USD im letzten Jahr. Im letzten Quartal berichtete Haemonetics Corp über Einnahmen in Höhe von 148.32M USD für den Zeitraum bis zum 2023-04-01, die aus dem leistungsstärksten Segment, Plasma products and services, stammten. United States trug mit 257.84M USD den höchsten Umsatz bei.

Nach Geschäftsbereich

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

Plasma products and services

HospitalHospital products and services

Blood Center products and services

FY2023

FY2022

FY2021

FY2020

FY2019

Plasma products and services

563.73M(48.24%)

427.61M(43.05%)

414.27M(47.59%)

537.23M(54.35%)

501.84M(51.87%)

HospitalHospital products and services

378.11M(32.35%)

329.43M(33.17%)

216.58M(24.88%)

198.42M(20.07%)

196.54M(20.31%)

Blood Center products and services

226.82M(19.41%)

236.16M(23.78%)

239.61M(27.53%)

252.83M(25.58%)

269.20M(27.82%)

Nach Region

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

United States

Europe

Asia

Japan

other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

1.01B(74.29%)

970.01M(74.10%)

842.90M(72.13%)

639.32M(64.37%)

522.61M(60.04%)

646.20M(65.37%)

606.85M(62.72%)

Europe

175.66M(12.91%)

160.14M(12.23%)

156.68M(13.41%)

163.52M(16.46%)

159.08M(18.27%)

153.35M(15.51%)

164.50M(17.00%)

Asia

92.31M(6.78%)

107.54M(8.21%)

104.14M(8.91%)

110.80M(11.16%)

105.82M(12.16%)

109.30M(11.06%)

118.70M(12.27%)

Japan

62.41M(4.59%)

58.09M(4.44%)

61.30M(5.24%)

75.56M(7.61%)

77.68M(8.92%)

72.22M(7.31%)

69.91M(7.23%)

other

19.54M(1.44%)

13.28M(1.01%)

3.65M(0.31%)

3.99M(0.40%)

5.28M(0.61%)

7.42M(0.75%)

7.62M(0.79%)